NCT00411372View on ClinicalTrials.gov

Shortness Of Breath Questionnaire Validation Study

PHASE3WithdrawnINTERVENTIONAL

0

Timeline

Start Date

November 30, 2006

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

fluticasone propionate/salmeterol 250/50mcg combination, salmeterol 50mcg

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY